Krane Funds Advisors, LLC manages the KMED issuer, a fund that primarily invests in emerging market companies within the health technology or health services industries, as classified by the FactSet Revere Business Industry Classification system. The fund, under normal conditions, allocates at least 80% of its net assets to instruments in its Underlying Index or similar economic instruments. The Underlying Index, developed by Solactive AG, comprises companies engaged in pharmaceuticals, biotechnology, managed healthcare, and related fields across various emerging markets, excluding shares listed locally in the UAE. To be included in the Index, securities must meet specific criteria related to market capitalization, trading volume, liquidity, and price. The Index is weighted by free-float-adjusted market capitalization, with limits to issuer and country exposure. While the Fund may invest up to 20% of its assets in non-Index instruments, it generally aims to track the Underlying Index through representative sampling. As of May 31, 2023, the Index included 95 securities with a market capitalization range of approximately $819.8 million to $235.9 billion, with Hong Kong and China being the largest markets represented. The Fund is structured as non-diversified and may participate in securities lending activities.
KMED Dividend, managed by Krane Funds Advisors, LLC, focuses on generating returns through dividend-paying stocks within the emerging market health technology and health services sectors. The fund aims to provide investors with regular income by investing in companies classified under the FactSet Revere Business Industry Classification system as operating in pharmaceuticals, biotechnology, managed healthcare, and related fields across emerging markets. KMED Dividend emphasizes companies with strong dividend histories and sustainable payout ratios. While prioritizing dividend-paying stocks, the fund may also seek capital appreciation opportunities within its investment universe. With a disciplined approach to selecting securities and managing dividends, KMED Dividend offers investors exposure to the potential growth and income opportunities present in emerging market healthcare sectors.
KMED Tracking, overseen by Krane Funds Advisors, LLC, is designed to closely mirror the performance of its underlying index, which comprises emerging market companies in the health technology and health services industries. The fund's investment strategy aims to replicate the index's returns through representative sampling, selecting a subset of securities that collectively reflect the index's composition and characteristics. By investing in a diversified portfolio of companies meeting specific criteria such as market capitalization, trading volume, and liquidity, KMED Tracking seeks to minimize tracking error and accurately track the index's performance over time. Through disciplined portfolio management and adherence to the index methodology, KMED Tracking offers investors a cost-effective means to gain exposure to the growth potential of emerging market healthcare sectors while maintaining alignment with the index's performance.
KMED Correlation, managed by Krane Funds Advisors, LLC, aims to provide investors with a vehicle that exhibits a high correlation to the performance of its underlying index. The fund utilizes a meticulous investment approach focused on selecting securities that closely mirror the composition and characteristics of the index. By investing predominantly in instruments within the health technology and health services industries of emerging markets, KMED Correlation seeks to replicate the index's movements with precision. Through ongoing monitoring and adjustments to the portfolio, the fund endeavors to maintain a strong correlation to the index over time, offering investors a reliable tool for gaining exposure to the targeted market segment. With an emphasis on achieving a consistent correlation to the underlying index, KMED Correlation provides investors with a transparent and effective means of tracking the performance of emerging market healthcare sectors.
KMED Sector, managed by Krane Funds Advisors, LLC, is dedicated to providing investors with targeted exposure to specific sectors within emerging market healthcare industries. The fund's investment strategy focuses on selecting companies operating in specialized segments such as pharmaceuticals, biotechnology, managed healthcare, and related areas classified under the FactSet Revere Business Industry Classification system. By concentrating on these distinct sectors, KMED Sector aims to capitalize on the growth potential and unique dynamics within each industry. Through diligent research and analysis, the fund seeks to identify promising investment opportunities that align with sector-specific trends and developments. With a portfolio tailored to capture the performance of select healthcare sectors in emerging markets, KMED Sector offers investors a focused approach to accessing potential growth opportunities while diversifying risks across different segments of the healthcare industry.
KMED Exposure, overseen by Krane Funds Advisors, LLC, offers investors a vehicle to gain targeted exposure to emerging market healthcare industries. The fund's investment strategy is designed to provide comprehensive coverage across various sectors within the healthcare landscape, including pharmaceuticals, biotechnology, managed healthcare, and related fields. By investing in a diversified portfolio of companies operating in these sectors, KMED Exposure aims to capture the growth potential and dynamic opportunities present in emerging market healthcare markets. Through rigorous research and analysis, the fund identifies and selects securities that offer exposure to key trends and advancements in healthcare, aiming to provide investors with a balanced and well-rounded investment approach. With a focus on capturing the broad spectrum of emerging market healthcare sectors, KMED Exposure presents investors with the opportunity to participate in the growth potential of this dynamic and rapidly evolving industry.
ETF Insider is a data-driven portfolio analytics and optimization platform that introduces a more efficient and practical way to visualize, analyze and optimize portfolios.
Rather than focusing on the surface-level attributes of ETFs and Mutual Funds, ETF Insider goes deeper by examining the underlying holdings of exchange traded products.
By organizing and structuring that data, investors can easily navigate within their overlapping layers.
This innovative perspective combined with modern data visualization and modeling tools, provides an entirely new approach to portfolio optimization that can quickly expose both portfolio inefficiencies and opportunities.
4 min readTHD VS kmed are specialized investment funds that focus on a diverse range of sectors in the financial market. these exchange-traded funds offer investors exposure to various industries and companies, presenting potential growth opportunities and risks. it's essential to understand the underlying assets and strategies of these etfs before considering an investment.
6 min readThe KMED ETF is a specialized investment fund that focuses on a specific sector. This exchange-traded fund offers investors exposure to a range of companies in this sector.
4 min readEWY VS FLKR are specialized investment funds that focus on a diverse range of sectors in the financial market. these exchange-traded funds offer investors exposure to various industries and companies, presenting potential growth opportunities and risks. it's essential to understand the underlying assets and strategies of these etfs before considering an investment.
ETF Insider is a novel portfolio optimization tool that uses the power of data visualization to gain insight into portfolio compositions, concentration risks, portfolio efficiency and more. Complex financial data can be transformed into visually appealing and easily digestible graphs and charts, allowing investors to quickly identify trends and make well-informed investment decisions. Not only does this save time, but it also increases the accuracy and effectiveness of portfolio management.
